Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$331M |
| 2 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$324M |
| 3 |
Salesforce
CRM
|
+$301M |
| 4 |
Adobe
ADBE
|
+$294M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$422M |
| 2 |
Lloyds Banking Group
LYG
|
+$252M |
| 3 |
Barclays
BCS
|
+$135M |
| 4 |
FIYY
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
|
+$72M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$62.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.08% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 8% |
| 5 | Consumer Staples | 5.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INVX
151
Innovex International
INVX
$1.96B
| $51M | 0.07% |
1,696,808
+12,067
| +0.7% | +$487K |
|
152
Stratasys
SSYS
$679M
| $50.7M | 0.07% |
2,813,874
-89,480
| -3% | -$1.87M |
|
153
Berkshire Hathaway Class B
BRK.B
$1.1T
| $50.6M | 0.07% |
247,876
-44,327
| -15% | -$9.26M |
|
154
Smith & Nephew
SNN
$13.3B
| $49.8M | 0.07% |
1,332,903
-99
| -0% | -$3.56K |
|
155
PayPal
PYPL
$48.9B
| $49.4M | 0.07% |
587,879
-5,506
| -0.9% | -$459K |
|
156
Charles River Laboratories
CRL
$11.2B
| $49.3M | 0.07% |
435,671
+56,394
| +15% | +$7.06M |
|
157
Goldman Sachs
GS
$300B
| $49.2M | 0.07% |
294,518
+7,997
| +3% | +$1.61M |
|
|
SEM
158
DELISTED
Select Medical
SEM
| $48.9M | 0.07% |
5,910,725
-1,996,947
| -25% | -$19.1M |
|
|
GTLS
159
DELISTED
Chart Industries
GTLS
| $48.5M | 0.07% |
745,941
+684,498
| +1,114% | +$45.2M |
|
160
Diageo
DEO
$49B
| $48.5M | 0.07% |
342,019
-41,999
| -11% | -$5.91M |
|
|
MDRX
161
DELISTED
Veradigm Inc. Common Stock
MDRX
| $48.3M | 0.07% |
5,009,018
+26,248
| +0.5% | +$293K |
|
162
Regal Rexnord
RRX
$13.7B
| $48.1M | 0.07% |
686,036
+2,121
| +0.3% | +$160K |
|
163
Darling Ingredients
DAR
$9.64B
| $47.8M | 0.07% |
2,483,127
+30,401
| +1% | +$616K |
|
164
Synaptics
SYNA
$4.19B
| $47.8M | 0.07% |
1,283,764
+342,909
| +36% | +$12.9M |
|
165
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $47M | 0.06% |
543,737
+66,280
| +14% | +$6M |
|
166
Helmerich & Payne
HP
$3.45B
| $47M | 0.06% |
979,648
+127,256
| +15% | +$7.81M |
|
|
LSI
167
DELISTED
Life Storage, Inc.
LSI
| $46.9M | 0.06% |
757,100
+6,983
| +0.9% | +$443K |
|
168
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $46.6M | 0.06% |
1,545,219
-61,955
| -4% | -$1.86M |
|
169
Core Laboratories
CLB
$490M
| $45.9M | 0.06% |
769,275
+47,867
| +7% | +$4.13M |
|
170
RLJ Lodging Trust
RLJ
$1.86B
| $45.6M | 0.06% |
2,780,687
+13,465
| +0.5% | +$262K |
|
171
Qualcomm
QCOM
$155B
| $44.9M | 0.06% |
789,789
+2,162
| +0.3% | +$131K |
|
172
Mid-America Apartment Communities
MAA
$15.4B
| $44.7M | 0.06% |
467,197
+3,615
| +0.8% | +$359K |
|
173
Integra LifeSciences
IART
$1.29B
| $42.6M | 0.06% |
945,619
+5,179
| +0.6% | +$284K |
|
174
MKS Inc
MKSI
$20.1B
| $42.1M | 0.06% |
651,951
+103,872
| +19% | +$7.51M |
|
175
Biogen
BIIB
$30B
| $41.5M | 0.06% |
137,952
+7,771
| +6% | +$2.48M |
|
Similar funds
Ken Fisher's Q4 2018 Portfolio in Review
As of Q4 2018, Ken Fisher held 954 positions worth $73.2B, down 11% from $82.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher deployed $3.18B of net new capital in Q4 2018, opening 84 new positions and adding to 428 existing holdings. Its largest new stake was Weibo: 2,764,345 shares worth $162M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vodafone, an estimated $422M trimmed.
- Ken Fisher's largest Q4 2018 buy was Weibo: 2,764,345 shares worth $162M.
- Ken Fisher added most to Cisco in Q4 2018, an estimated $331M increase.
- Ken Fisher's biggest Q4 2018 reduction was Vodafone, cutting an estimated $422M.
- Ken Fisher fully exited Luxottica Group in Q4 2018, selling an estimated $51M.
- Ken Fisher's ten largest holdings make up 26% of its $73.2B portfolio in Q4 2018.
- Ken Fisher opened 84 new positions and closed 88 in Q4 2018.
- Ken Fisher's portfolio value fell 11% quarter-over-quarter to $73.2B.
Based on Fisher Asset Management's 13F filing for Q4 2018, filed 25 Jan 2019.